English Journal

[Diagnosis and treatment of non-Hodgkin lymphoma in Netherlands: variation in guidelines and in practice].

Faber LM, van Agthoven M, Uyl-de Groot CA, Löwenberg B, Huijgens PC.SourceAcademisch Ziekenhuis Vrije Universiteit, afd. Hematologie, Amsterdam.
Nederlands tijdschrift voor geneeskunde.Ned Tijdschr Geneeskd.2000 Jun 17;144(25):1223-7.
OBJECTIVE: To investigate current guidelines for diagnosis and treatment of intermediate or high grade non-Hodgkin's lymphoma (NHL), stage I-IV (Burkitt's and lymphoblastic lymphoma excluded) and to compare this with current clinical practice.DESIGN: Descriptive.METHOD: An inventory of guidelines fo
PMID 10897302

Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3.

Borner MM, Myers CE, Sartor O, Sei Y, Toko T, Trepel JB, Schneider E.SourceClinical Pharmacology Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.
Cancer research.Cancer Res.1995 May 15;55(10):2122-8.
The propensity of a cell to undergo apoptosis has been proposed to be a determinant for chemotherapy sensitivity that is not directly dependent on specific drug-target interactions. Androgen-independent prostate cancer is typically refractory to cytotoxic drugs, and we tested whether this is due to
PMID 7743512